CDR 135 Pill - blue & yellow capsule-shape
Pill with imprint CDR 135 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Micro Labs Limited.
Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CDR 135
Fenofibric Acid Delayed-Release
- Imprint
- CDR 135
- Strength
- 135 mg
- Color
- Blue & Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Micro Labs Limited
- National Drug Code (NDC)
- 42571-0348
More about fenofibric acid
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (25)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: fibric acid derivatives
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.